Gastroesophageal reflux disease (GERD) is one of the most frequent gastrointestinal
disorders. Proton pump inhibitors (PPIs) are effective in healing lesions and improving …

Introduction Gastroesophageal reflux disease (GERD) is a very common worldwide
condition, affecting about 15–20% of the whole population, and representing a major burden …

Гастроэзофагеальная рефлюксная болезнь (ГЭРБ) характеризуется высокой
заболеваемостью и значительным снижением качества жизни пациентов, а также …

A meta-analysis of 1437 patients from 14 RCTs in China showed that prokinetics combined
with PPI were more effective in alleviating symptoms than PPI monotherapy; however, no …

The underlying causes of heartburn, characteristic symptom of gastroesophageal reflux
disease (GERD), remain incompletely understood. Superficial afferent innervation of the …

Proton pump inhibitors (PPIs), the most commonly used antisecretory medi-cations in the
management of reflux illness, virtually eliminate elective surgery for ulcer disease, and …

Gastroesophageal reflux disease (GERD) affects one in five Americans and is one of the
most common diagnoses managed in the outpatient gastroenterology clinic. 1, 2 According …

Background Oesophageal disorders and chronic liver disease are common worldwide and
significantly impact quality of life. The intricate link between these conditions, including how …

There is no clear consensus regarding the precise definition of the term refractory GERD.
GERD can be complicated by reflux esophagitis and peptic esophageal strictures, which …

Gastroesophageal reflux disease (GERD) is characterized by high morbidity and a
significant decrease in the quality of life of patients, and is a major risk factor for esophageal …